Health

Sanofi Plans to Cut the Price of Insulin


Facing pressure to follow a wave of industry price cuts, the drug maker Sanofi said on Thursday that it would reduce the sticker price of its most commonly used insulin by 78 percent.

The company said it would also cap, at $35 per month, that product’s out-of-pocket costs for diabetes patients with private health plans.

Sanofi’s moves, which will go into effect at the start of next year, follow similar announcements this month by the two other large insulin manufacturers, Eli Lilly and Novo Nordisk. Together, the three companies control about 90 percent of the insulin market in the United States.

The price cuts are likely to reduce how often Americans with diabetes struggle to pay for insulin, which millions depend on to stay alive. A federal law that went into effect at the start of this year had already capped out-of-pocket costs for insulin at $35 per month for people covered by Medicare.



Sahred From Source link Health

Leave a Reply

Your email address will not be published. Required fields are marked *